The global microbiology testing market is expanding as rising antimicrobial resistance (AMR), laboratory automation adoption, and tightening pharmaceutical and food-safety regulations accelerate demand for rapid, accurate pathogen identification and susceptibility testing.

The market was valued at approximately USD 5.77 billion in 2024, about USD 6.13 billion in 2025, and is projected to reach roughly USD 11.32 billion by 2035, growing at a CAGR of approximately 6.32%. Growth is supported by rising antimicrobial resistance burden, laboratory automation and workforce shortages, tightening pharmaceutical and food-safety regulations, syndromic molecular panel adoption, and hospital infrastructure expansion in emerging economies.marketresearchfuture

Clinical diagnostics anchors the application landscape, with acute-care hospitals driving the bulk of blood-culture, urine-culture, and respiratory specimen volumes. Pharmaceutical QC testing is accelerating as global regulators mandate shorter turnaround sterility and bioburden release protocols, creating upgrade pressure across contract manufacturing organizations.

Culture-based testing remains indispensable, serving as the confirmatory backbone against which newer technologies are validated. Molecular diagnostics are gaining ground rapidly through syndromic panels that detect 20+ targets from a single specimen in under two hours, dramatically improving time-to-treatment in critical-care settings.

North America led the market with over 49.91% share, generating around USD 2.9 billion in revenue. Key players include bioMérieux, Becton, Dickinson (BD), Danaher (Beckman Coulter / Cepheid), Thermo Fisher Scientific, Bruker, Merck KGaA, Bio-Rad Laboratories, and Hologic.

Read more: Microbiology Testing Market Size & Global Report

People Also Ask

Q1. What is driving the microbiology testing market?
Rising antimicrobial resistance, laboratory automation, tightening regulations, syndromic molecular panel adoption, and hospital infrastructure expansion are major drivers.

Q2. Which technology is growing fastest?
Molecular diagnostics are the fastest-growing technology segment with a 13.2% CAGR through 2035.

Tags: microbiology testing, antimicrobial resistance, laboratory automation, molecular diagnostics, clinical diagnostics